Frank Pallone actually said...
the purpose of the breakthrough therapy designation was to, as you say, Mr. Pallone, too, advance and give the flexibility for FDA to respond to the current state of science
Context
Pallone discusses the FDA's flexibility in drug approval processes.
05/19/2014